Evidence map›Paper›PMID 26810659›Full record

ArticleAntimicrobial agents and chemotherapy2016

Identification of EnvC and Its Cognate Amidases as Novel Determinants of Intrinsic Resistance to Cationic Antimicrobial Peptides.

Tamiko Oguri, Won-Sik Yeo, Taeok Bae, Hyunwoo Lee

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Outer membrane barrier impairment byMicrobiology (Reading, England) · 2024
    Article
  4. Article
  5. Effects of LPS Composition inFrontiers in microbiology · 2022
    Article
  6. Review
  7. Insights into bacterial cell division from a structure of EnvC bound to the FtsX periplasmic domain.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Article
  10. Evolution of Antibiotic Resistance without Antibiotic Exposure.Antimicrobial agents and chemotherapy · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Tamiko OguriCenter for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA.
Won-Sik YeoDepartment of Microbiology and Immunology, Indiana University School of Medicine-Northwest, Gary, Indiana, USA.
Taeok BaeDepartment of Microbiology and Immunology, Indiana University School of Medicine-Northwest, Gary, Indiana, USA.
Hyunwoo LeeCenter for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA hlee31@uic.edu.
University of Illinois Chicago · USIndiana University Northwest · USIndiana University School of Medicine

Funding

Genetic determinants of antimicrobial peptide resistance in Gram negative bacteriR21AI076678 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LEE, HYUNWOO · 2009 to 2010
$432k
NIAID NIH HHS AI076678NIAID NIH HHS R21 AI076678
6 · The paper itself

Abstract

Cationic antimicrobial peptides (CAMPs) are an essential part of the innate immune system. Some Gram-negative enteric pathogens, such asSalmonella enterica, show intrinsic resistance to CAMPs. However, the molecular basis of intrinsic resistance is poorly understood, largely due to a lack of information about the genes involved. In this study, using a microarray-based genomic technique, we screened the Keio collection of 3,985Escherichia colimutants for altered susceptibility to human neutrophil peptide 1 (HNP-1) and identifiedenvCandzapBas novel genetic determinants of intrinsic CAMP resistance. In CAMP killing assays, anE. coliΔenvCEcor ΔzapBEcmutant displayed a distinct profile of increased susceptibility to both LL-37 and HNP-1. Both mutants, however, displayed wild-type resistance to polymyxin B and human β-defensin 3 (HBD3), suggesting that the intrinsic resistance mediated by EnvC or ZapB is specific to certain CAMPs. A correspondingSalmonellaΔenvCSemutant showed similarly increased CAMP susceptibility. TheenvCmutants of bothE. coliandS. entericadisplayed increased surface negativity and hydrophobicity, which partly explained the increased CAMP susceptibility. However, the ΔenvCEcmutant, but not the ΔenvCSemutant, was defective in outer membrane permeability, excluding this defect as a common factor contributing to the increased CAMP susceptibility. Animal experiments showed that theSalmonellaΔenvCSemutant had attenuated virulence. Taken together, our results indicate that the role ofenvCin intrinsic CAMP resistance is likely conserved among Gram-negative enteric bacteria, demonstrate the importance of intrinsic CAMP resistance for full virulence ofS. enterica, and provide insight into distinct mechanisms of action of CAMPs.

Indexed as

alpha-DefensinsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial Proteinsbeta-DefensinsCathelicidinsCell Cycle ProteinsCell Membrane PermeabilityDrug Resistance, BacterialEndopeptidasesEscherichia coliGene ExpressionHydrophobic and Hydrophilic InteractionsMicrobial Sensitivity TestsMutationPolymyxin Balpha-DefensinsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial Proteinsbeta-DefensinsCathelicidinsCell Cycle ProteinsDEFB103A protein, humanEndopeptidaseshuman neutrophil peptide 1Polymyxin B

Identifiers

PMID26810659
PMCPMC4808223
OpenAlexW2259553490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.